Sglt2 Inhibitors Dramatically Reduce Mortality And Cardiovascular Complications In Post-mi Patients With Mildly Reduced Ejection Fraction: A Large-scale Real-world Evidence Analysis

Journal of Cardiac Failure 2026

View at publisher

Authors: Godbless Ebruvwiyor Ajenaghughrure, Karldon Iwuchukwu Nwaezeapu, Kayode Emmanuel Ogunniyi

DOI: 10.1016/j.cardfail.2025.11.271

Cited by: 0

Fields of Study & Subjects

Heart Failure Treatment and Management Diabetes Treatment and Management Cardiovascular Function and Risk Factors